General Information of the Compound
Compound ID
CP0085943
Compound Name
3-(2,4,6-Trimethoxybenzylidene)indolin-2-one
    Show/Hide
Synonyms
IC 261
IC-261
IC261
    Show/Hide
Structure
Formula
C18H17NO4
Molecular Weight
311.337
Canonical SMILES
COc1cc(OC)c(\C=C2\C(=O)Nc3ccccc23)c(OC)c1
    Show/Hide
InChI
InChI=1S/C18H17NO4/c1-21-11-8-16(22-2)14(17(9-11)23-3)10-13-12-6-4-5-7-15(12)19-18(13)20/h4-10H,1-3H3,(H,19,20)/b13-10+
    Show/Hide
InChIKey
JBJYTZXCZDNOJW-JLHYYAGUSA-N
Physicochemical Property
logP
3.2051
Rotatable Bonds
4
Heavy Atom Count
23
Polar Areas
56.79
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5288600
SID: 15272204
ChEMBL ID
CHEMBL489156
DrugBank ID
DB03083
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000015 SW480 Homo sapiens (Human)  1
1
Potency ~ 2592.9 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( IC261 )
Drug Name IC261
Indication
Pancreatic cancer
Preclinical
Target(s)
Casein kinase I alpha (CSNK1A1)
Inhibitor
Casein kinase I delta (CSNK1D)
Inhibitor
Casein kinase I epsilon (CSNK1E)
Inhibitor